Keyphrases
Neuroprotection
100%
Transient Receptor Potential Vanilloid 1 (TRPV1)
100%
Neuroregeneration
100%
Estrogen Therapy
100%
Aging
75%
Neurodegenerative Diseases
50%
Regeneration
50%
Hormone Therapy
50%
Nervous System
25%
Health Outcomes
25%
Pleiotropic Effects
25%
Survival Rate
25%
Menopause
25%
Cognitive Impairment
25%
Blood-brain Barrier
25%
Damaged Tissue
25%
Major Determinants
25%
Neurogenesis
25%
Mental Health
25%
Neural Stem Cells
25%
Function Integration
25%
Estrogen
25%
Neuronal Loss
25%
Mental Disease
25%
Gonad
25%
Steroidal
25%
Brain Health
25%
Cognitive Health
25%
Sensory Cells
25%
Hypophysis
25%
Stem Cell Progenitors
25%
Neuroendocrine Axis
25%
Transient Receptor Potential Cation Channel Subfamily V Member 1
25%
Mental Impairment
25%
FLANN
25%
Sexual Steroids
25%
Cognitive Enhancer
25%
Menopause Symptoms
25%
Clinical Model
25%
Plasticity Mechanisms
25%
Andropause
25%
Physical Degradation
25%
Production Decline
25%
Medicine and Dentistry
Neuroprotection
100%
TRPV1
100%
Estrogen Therapy
100%
Nerve Regeneration
100%
Degenerative Disease
50%
Hormone Therapy
50%
Nervous System
25%
Deterioration
25%
Symptom
25%
Blood Brain Barrier
25%
Mental Health
25%
Health Outcomes
25%
Survival Rate
25%
Neurogenesis
25%
Pleiotropy
25%
Transient Receptor Potential Channel
25%
Enhancer Region
25%
Andropause
25%
Neural Stem Cell
25%
Gonad
25%
Pituitary Gland
25%
Neuroscience
Neuroprotection
100%
TRPV1
100%
Neuroregeneration
100%
Neurodegenerative Disorder
50%
Hormone Therapy
50%
Nervous System
25%
Neurogenesis
25%
Blood Brain Barrier
25%
Neural Network
25%
Neural Stem Cell
25%
Agonist
25%
Transient Receptor Potential Channel
25%
Enhancer Region
25%
Pituitary Gland
25%
Andropause
25%
Biochemistry, Genetics and Molecular Biology
TRPV1
100%
Nerve Regeneration
100%
Enhancer Region
33%
Pleiotropy
33%
Nervous System Development
33%
Stem Cell
33%
Agonist
33%
Receptor Potential
33%
Mental Health
33%
Blood Brain Barrier
33%
Survival Rate
33%
Andropause
33%